These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8881695)

  • 1. Modulation of serum eosinophil cationic protein levels by cyclosporin in severe atopic dermatitis.
    Caproni M; D'Agata A; Cappelli G; Fabbri P
    Br J Dermatol; 1996 Aug; 135(2):336-7. PubMed ID: 8881695
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dexamethasone and cyclosporin A on the accumulation of eosinophils in acute cutaneous inflammation in the guinea-pig.
    Teixeira MM; Williams TJ; Hellewell PG
    Br J Pharmacol; 1996 May; 118(2):317-24. PubMed ID: 8735633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD11b on eosinophils in atopic dermatitis: downregulation by cyclosporin A and upregulation by interleukin 5.
    Yamada H; Kurashimo S; Chihara J; Matsukura M; Yudate T; Tezuka T
    Int Arch Allergy Immunol; 1999; 120 Suppl 1():100-3. PubMed ID: 10529615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD30 and cyclosporine in severe atopic dermatitis.
    Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
    Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclosporin A in atopic dermatitis].
    Cordero Miranda MA; Casas Becerra B; Reyes Ruiz NI; Avila Castañón L; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2002; 49(4):129-34. PubMed ID: 12374046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Antipruritic Mechanism of Cyclosporine A in Atopic Dermatitis.
    Ko KC; Tominaga M; Kamata Y; Umehara Y; Matsuda H; Takahashi N; Kina K; Ogawa M; Ogawa H; Takamori K
    Acta Derm Venereol; 2016 Jun; 96(5):624-9. PubMed ID: 26671728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Hochu-ekki-to in patients with atopic dermatitis resistant to conventional treatment.
    Kobayashi H; Mizuno N; Teramae H; Kutsuna H; Ueoku S; Onoyama J; Yamanaka K; Fujita N; Ishii M
    Int J Tissue React; 2004; 26(3-4):113-7. PubMed ID: 15648444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine treatment decreases the percentage of cutaneous lymphocyte antigen (CLA)(+)CD4(+) T cells in children with severe atopic dermatitis.
    Lee SY; Shim JY; Kim JH; Kim BS; Seo HJ; Choi SO; Jang SO; Hong SJ
    Allergy; 2004 Oct; 59(10):1129-30. PubMed ID: 15355478
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both.
    Baumgrass R; Brandt C; Wegner F; Abdollahnia M; Worm M
    J Allergy Clin Immunol; 2010 Jul; 126(1):183-4; author reply 184. PubMed ID: 20542321
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial.
    Jin SY; Lim WS; Sung NH; Cheong KA; Lee AY
    Dermatol Ther; 2015; 28(1):44-51. PubMed ID: 25113885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis.
    Amon U; Memmel U; Stoll R; Amon S
    Acta Derm Venereol; 2000; 80(4):284-6. PubMed ID: 11028863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of atopic dermatitis with systemic immunosuppressive agents.
    Akhavan A; Rudikoff D
    Clin Dermatol; 2003; 21(3):225-40. PubMed ID: 12781440
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis.
    Ishii E; Yamamoto S; Sakai R; Hamasaki Y; Miyazaki S
    J Pediatr; 1996 Jan; 128(1):152-5. PubMed ID: 8551410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The eosinophil and atopic dermatitis].
    Orea Solano M; Cueva Velázquez J
    Alergia; 1978 Oct; 25(4):175-80. PubMed ID: 747216
    [No Abstract]   [Full Text] [Related]  

  • 15. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.
    Jenerowicz D; Czarnecka-Operacz M; Silny W
    Acta Dermatovenerol Croat; 2006; 14(2):73-80. PubMed ID: 16859611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
    Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
    Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory atopic dermatitis treated with low dose cyclosporin.
    Yu FC; Gibbon GW; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):127-31. PubMed ID: 12197567
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis.
    Otsuka A; Tanioka M; Nakagawa Y; Honda T; Ikoma A; Miyachi Y; Kabashima K
    Eur J Dermatol; 2011; 21(5):816-7. PubMed ID: 21727058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.